Cargando…

PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients

Detalles Bibliográficos
Autores principales: Hofer, F, Endres, T, Kortus-Götze, B, Blank, N, Weißbarth-Riedel, E, Schütz, C, Kallinich, T, Krause, K, Rietschel, C, Horneff, G, Kuemmerle-Deschner, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043406/
http://dx.doi.org/10.1186/1546-0096-11-S2-P214
_version_ 1782318898481201152
author Hofer, F
Endres, T
Kortus-Götze, B
Blank, N
Weißbarth-Riedel, E
Schütz, C
Kallinich, T
Krause, K
Rietschel, C
Horneff, G
Kuemmerle-Deschner, J
author_facet Hofer, F
Endres, T
Kortus-Götze, B
Blank, N
Weißbarth-Riedel, E
Schütz, C
Kallinich, T
Krause, K
Rietschel, C
Horneff, G
Kuemmerle-Deschner, J
author_sort Hofer, F
collection PubMed
description
format Online
Article
Text
id pubmed-4043406
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40434062014-06-17 PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients Hofer, F Endres, T Kortus-Götze, B Blank, N Weißbarth-Riedel, E Schütz, C Kallinich, T Krause, K Rietschel, C Horneff, G Kuemmerle-Deschner, J Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4043406/ http://dx.doi.org/10.1186/1546-0096-11-S2-P214 Text en Copyright © 2013 Hofer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Hofer, F
Endres, T
Kortus-Götze, B
Blank, N
Weißbarth-Riedel, E
Schütz, C
Kallinich, T
Krause, K
Rietschel, C
Horneff, G
Kuemmerle-Deschner, J
PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
title PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
title_full PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
title_fullStr PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
title_full_unstemmed PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
title_short PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
title_sort pres-final-2224: canakinumab treatment regimens in caps-patients
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043406/
http://dx.doi.org/10.1186/1546-0096-11-S2-P214
work_keys_str_mv AT hoferf presfinal2224canakinumabtreatmentregimensincapspatients
AT endrest presfinal2224canakinumabtreatmentregimensincapspatients
AT kortusgotzeb presfinal2224canakinumabtreatmentregimensincapspatients
AT blankn presfinal2224canakinumabtreatmentregimensincapspatients
AT weißbarthriedele presfinal2224canakinumabtreatmentregimensincapspatients
AT schutzc presfinal2224canakinumabtreatmentregimensincapspatients
AT kallinicht presfinal2224canakinumabtreatmentregimensincapspatients
AT krausek presfinal2224canakinumabtreatmentregimensincapspatients
AT rietschelc presfinal2224canakinumabtreatmentregimensincapspatients
AT horneffg presfinal2224canakinumabtreatmentregimensincapspatients
AT kuemmerledeschnerj presfinal2224canakinumabtreatmentregimensincapspatients